China OKs mixed-use COVID-19 vaccine trials
Holly Chik, South China Morning Post
Posted at Aug 11 01:32 PM
China’s medical products regulator has approved local trials for the combined use of the Chinese Sinovac COVID-19 vaccine and a DNA vaccine developed by American biotech company Inovio. The trials are set to begin in the autumn in China and will evaluate the safety and ability of the combined vaccines to induce an immune response in adults, Inovio said. Read more »